These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 30465238)

  • 1. Current status of immunotherapy in metastatic colorectal cancer.
    Wrobel P; Ahmed S
    Int J Colorectal Dis; 2019 Jan; 34(1):13-25. PubMed ID: 30465238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for colorectal cancer.
    Yu B; Kang J; Lei H; Li Z; Yang H; Zhang M
    Front Immunol; 2024; 15():1433315. PubMed ID: 39238638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review on the immunotherapy strategies against metastatic colorectal carcinoma.
    Signorini L; Delbue S; Ferrante P; Bregni M
    Immunotherapy; 2016 Oct; 8(10):1245-61. PubMed ID: 27605072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current advancements and future perspectives of immunotherapy in colorectal cancer research.
    Kishore C; Bhadra P
    Eur J Pharmacol; 2021 Feb; 893():173819. PubMed ID: 33347822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-Oncolytic Viruses: Emerging Options in the Treatment of Colorectal Cancer.
    Kana SI; Essani K
    Mol Diagn Ther; 2021 May; 25(3):301-313. PubMed ID: 33713031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
    Picard E; Verschoor CP; Ma GW; Pawelec G
    Front Immunol; 2020; 11():369. PubMed ID: 32210966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of colorectal cancer: new perspectives after a long path.
    Correale P; Botta C; Ciliberto D; Pastina P; Ingargiola R; Zappavigna S; Tassone P; Pirtoli L; Caraglia M; Tagliaferri P
    Immunotherapy; 2016 Nov; 8(11):1281-1292. PubMed ID: 27993089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell-based immunotherapy in colorectal cancer.
    Feng M; Zhao Z; Yang M; Ji J; Zhu D
    Cancer Lett; 2021 Feb; 498():201-209. PubMed ID: 33129958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for metastatic colorectal cancer: present status and new options.
    Ellebaek E; Andersen MH; Svane IM; Straten PT
    Scand J Gastroenterol; 2012 Mar; 47(3):315-24. PubMed ID: 22214467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for colorectal cancer.
    Maxwell-Armstrong CA; Durrant LG; Scholefield JH
    Am J Surg; 1999 Apr; 177(4):344-8. PubMed ID: 10326858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer immunotherapy.
    Xiang B; Snook AE; Magee MS; Waldman SA
    Discov Med; 2013 May; 15(84):301-8. PubMed ID: 23725603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy regimens for metastatic colorectal carcinomas.
    Bashir B; Snook AE
    Hum Vaccin Immunother; 2018 Feb; 14(2):250-254. PubMed ID: 29083978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for colorectal cancer.
    Koido S; Ohkusa T; Homma S; Namiki Y; Takakura K; Saito K; Ito Z; Kobayashi H; Kajihara M; Uchiyama K; Arihiro S; Arakawa H; Okamoto M; Gong J; Tajiri H
    World J Gastroenterol; 2013 Dec; 19(46):8531-42. PubMed ID: 24379570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer.
    Zheng Y; Fu Y; Wang PP; Ding ZY
    Dis Markers; 2022; 2022():8270305. PubMed ID: 35211210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combating colorectal cancer with immunotherapy: Where are we?
    Gupta R; Bhatt LK; Prabhavalkar KS
    Drugs Today (Barc); 2019 Aug; 55(8):513-528. PubMed ID: 31461088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy.
    Ghidini M; Fusco N; Salati M; Khakoo S; Tomasello G; Petrelli F; Trapani D; Petrillo A
    Curr Drug Targets; 2021; 22(9):1021-1033. PubMed ID: 33563194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches.
    Tintelnot J; Stein A
    World J Gastroenterol; 2019 Aug; 25(29):3920-3928. PubMed ID: 31413527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal Cancer Immunotherapy: Options and Strategies.
    Johdi NA; Sukor NF
    Front Immunol; 2020; 11():1624. PubMed ID: 33042104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant Melanoma.
    Cavalcante L; Chowdhary A; Sosman JA; Chandra S
    Am J Clin Dermatol; 2018 Oct; 19(5):657-670. PubMed ID: 29961183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.